JBM (Healthcare) Ltd.

As of March 31, 2026, JBM (Healthcare) Ltd. carries a market capitalization of 2.18B, placing it among publicly traded companies globally. Its enterprise value stands at 2.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

JBM (Healthcare) Ltd.'s next confirmed earnings release is scheduled for November 17, 2026.

As of March 31, 2026, JBM (Healthcare) Ltd. has 819.80M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, JBM (Healthcare) Ltd. maintains a current ratio of 1.90, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, JBM (Healthcare) Ltd.'s stock has declined approximately 45.39% over the past 52 weeks. The 50-day moving average sits at 1.73, while the 200-day moving average is 2.28.

As of March 31, 2026, JBM (Healthcare) Ltd. holds 119.94M in cash and equivalents against 393.72M in total debt, resulting in a net debt position of 245.50M. Total book value stands at 1.08B, with working capital of 230.77M providing operational flexibility.